L-arginine is a substrate for nitric oxide synthase (NOS) responsible for the production of NO. This investigation studied the effect of apocynin, an NADPH oxidase inhibitor and catalase, an H2O2 scavenger on L-arginine induced oxidative stress and hypotension. Forty Wistar-Kyoto rats were treated for 14 days with vehicle, L-arginine (12.5mg/ml p.o.), L-arginine+apocynin (2.5mmol/L p.o.), L-arginine+catalase (10000U/kg/day i.p.) and L-arginine plus apocynin+catalase respectively. Weekly renal functional and hemodynamic parameters were measured and kidneys harvested at the end of the study for histopathological and renal NADPH oxidase 4 (Nox4) assessments. L-arginine administration in normotensive rats decreased systolic blood pressure (120±2 vs 91±2mmHg) and heart rate (298±21 vs 254±15b/min), enhanced urinary output (21.5±4.2 vs 32±1.9ml/24h , increased creatinine clearance (1.72±0.56 vs 2.62±0.40ml/min/kg), and fractional sodium excretion (0.88±0.16 vs 1.18±0.16 %), caused proteinuria (28.10±1.93 vs 35.26±1.69mg/kg/day) and a significant decrease in renal cortical blood perfusion (292±3 vs 258±5bpu) and pulse wave velocity (3.72±0.20 vs 2.84±0.13m/s) (all P<0.05). L-arginine increased plasma malondialdehyde (by ~206 % P<0.05) and NO (by~51 %, P<0.05) but decreased superoxide dismutase (by~31 %, P<0.05) and total antioxidant capacity (by~35 %, P<0.05) compared to control. Renal Nox4 mRNA activity was approximately 2.1 fold higher (P<0.05) in the L-arginine treated rats but was normalized by apocynin and apocynin plus catalase treatment. Administration of apocynin and catalase, but not catalase alone to rats fed L-arginine, restored the deranged renal function and structure, prevented hypotension and enhanced the antioxidant capacity and suppressed Nox4 expression. These findings suggest that apocynin and catalase might be used prophylactically in states of oxidative stress.

Cardiovascular and Renal Physiology Research Laboratory School of Pharmaceutical Sciences Universiti Sains Malaysia Penang Malaysia

Department of Endocrinology School of Medicine University of Virginia Charlottesville VA USA

Department of Pharmacology and Toxicology School of Medicine Virginia Commonwealth University Richmond VA USA

Department of Pharmacy Abasyn University Islamabad Campus Park Road Islamabad Pakistan

Department of Pharmacy Islamia University of Bahawalpur Pakistan

Department of Physiology University College Cork Cork Ireland

Discipline of Pharmacology School of Pharmaceutical Sciences Universiti Sains Malaysia Penang Malaysia

Literatura

000      

00000naa a2200000 a 4500

001      

bmc21028141

003      

CZ-PrNML

005      

20211129135919.0

007      

ta

008      

211105s2020 xr d f 000 0|eng||

009      

AR

024    7_

$a 10.33549/physiolres.934426 $2 doi

035    __

$a (PubMed)33210935

040    __

$a ABA008 $b cze $d ABA008 $e AACR2

041    0_

$a eng

044    __

$a xr

100    1_

$a Chia, T. Y. $u Cardiovascular and Renal Physiology Research Laboratory, School of Pharmaceutical Sciences, Universiti Sains Malaysia, Penang, Malaysia

245    14

$a The restorative effect of apocynin and catalase in l-arginine induced hypotension on normotensive subjects - the role of oxidative stress / $c T. Y. Chia, V. Murugaiyah, M. A. Sattar, N. A. K. Khan, A. Ahmad, M. H. Abdulla, E. J. Johns, H. Y. Mei, S. Akhtar, F. U. Ahmad

504    __

$a Literatura

520    9_

$a L-arginine is a substrate for nitric oxide synthase (NOS) responsible for the production of NO. This investigation studied the effect of apocynin, an NADPH oxidase inhibitor and catalase, an H2O2 scavenger on L-arginine induced oxidative stress and hypotension. Forty Wistar-Kyoto rats were treated for 14 days with vehicle, L-arginine (12.5mg/ml p.o.), L-arginine+apocynin (2.5mmol/L p.o.), L-arginine+catalase (10000U/kg/day i.p.) and L-arginine plus apocynin+catalase respectively. Weekly renal functional and hemodynamic parameters were measured and kidneys harvested at the end of the study for histopathological and renal NADPH oxidase 4 (Nox4) assessments. L-arginine administration in normotensive rats decreased systolic blood pressure (120±2 vs 91±2mmHg) and heart rate (298±21 vs 254±15b/min), enhanced urinary output (21.5±4.2 vs 32±1.9ml/24h , increased creatinine clearance (1.72±0.56 vs 2.62±0.40ml/min/kg), and fractional sodium excretion (0.88±0.16 vs 1.18±0.16 %), caused proteinuria (28.10±1.93 vs 35.26±1.69mg/kg/day) and a significant decrease in renal cortical blood perfusion (292±3 vs 258±5bpu) and pulse wave velocity (3.72±0.20 vs 2.84±0.13m/s) (all P<0.05). L-arginine increased plasma malondialdehyde (by ~206 % P<0.05) and NO (by~51 %, P<0.05) but decreased superoxide dismutase (by~31 %, P<0.05) and total antioxidant capacity (by~35 %, P<0.05) compared to control. Renal Nox4 mRNA activity was approximately 2.1 fold higher (P<0.05) in the L-arginine treated rats but was normalized by apocynin and apocynin plus catalase treatment. Administration of apocynin and catalase, but not catalase alone to rats fed L-arginine, restored the deranged renal function and structure, prevented hypotension and enhanced the antioxidant capacity and suppressed Nox4 expression. These findings suggest that apocynin and catalase might be used prophylactically in states of oxidative stress.

650    _2

$a acetofenony $x farmakologie $7 D000098

650    _2

$a zvířata $7 D000818

650    _2

$a antioxidancia $x farmakologie $7 D000975

650    _2

$a arginin $x farmakologie $7 D001120

650    _2

$a krevní tlak $x účinky léků $7 D001794

650    _2

$a katalasa $x farmakologie $7 D002374

650    _2

$a modely nemocí na zvířatech $7 D004195

650    _2

$a hypotenze $x chemicky indukované $x farmakoterapie $x metabolismus $x patologie $7 D007022

650    _2

$a ledviny $x účinky léků $x metabolismus $x patologie $7 D007668

650    _2

$a mužské pohlaví $7 D008297

650    _2

$a NADPH-oxidasa 4 $x metabolismus $7 D000074663

650    _2

$a oxidační stres $x účinky léků $7 D018384

650    _2

$a analýza pulzové vlny $x metody $7 D063177

650    _2

$a krysa rodu Rattus $7 D051381

650    _2

$a potkani inbrední WKY $7 D011921

655    _2

$a časopisecké články $7 D016428

700    1_

$a Murugaiyah, V. $u Discipline of Pharmacology, School of Pharmaceutical Sciences, Universiti Sains Malaysia, Penang, Malaysia

700    1_

$a Sattar, M. A. $u Cardiovascular and Renal Physiology Research Laboratory, School of Pharmaceutical Sciences, Universiti Sains Malaysia, Penang, Malaysia

700    1_

$a Khan, N. A. K. $u Cardiovascular and Renal Physiology Research Laboratory, School of Pharmaceutical Sciences, Universiti Sains Malaysia, Penang, Malaysia

700    1_

$a Ahmad, A. $u Department of Pharmacology and Toxicology, School of Medicine, Virginia Commonwealth University, Richmond, VA, USA $u Department of Pharmacy, Abasyn University Islamabad Campus, Park Road, Islamabad, Pakistan

700    1_

$a Abdulla, M. H. $u Department of Physiology, University College Cork, Cork, Ireland

700    1_

$a Johns, E. J. $u Department of Physiology, University College Cork, Cork, Ireland

700    1_

$a Mei, H. Y. $u Cardiovascular and Renal Physiology Research Laboratory, School of Pharmaceutical Sciences, Universiti Sains Malaysia, Penang, Malaysia

700    1_

$a Akhtar, S. $u Department of Endocrinology, School of Medicine, University of Virginia, Charlottesville, VA, USA

700    1_

$a Ahmad, F. U. $u Department of Pharmacy, Islamia University of Bahawalpur, Pakistan

773    0_

$w MED00003824 $t Physiological research $x 1802-9973 $g Roč. 69, č. 6 (2020), s. 1051-1066

856    41

$u https://pubmed.ncbi.nlm.nih.gov/33210935 $y Pubmed

910    __

$a ABA008 $b A 4120 $c 266 $y p $z 0

990    __

$a 20211105 $b ABA008

991    __

$a 20211124101224 $b ABA008

999    __

$a ok $b bmc $g 1728748 $s 1148686

BAS    __

$a 3

BAS    __

$a PreBMC

BMC    __

$a 2020 $b 69 $c 6 $d 1051-1066 $e 20201119 $i 1802-9973 $m Physiological research $n Physiol. Res. (Print) $x MED00003824

LZP    __

$b NLK118 $a Pubmed-20211105